resTORbio, Inc.·4

Feb 28, 5:34 PM ET

Manning Meredith 4

4 · resTORbio, Inc. · Filed Feb 28, 2019

Insider Transaction Report

Form 4
Period: 2019-02-27
Manning Meredith
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-27+26,00026,000 total
    Exercise: $8.53Exp: 2029-02-26Common Stock (26,000 underlying)
Footnotes (1)
  • [F1]25% of the shares shall vest on February 27, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION